Experimental treatments could help US Ebola patient
Published on: May 23, 2026, 2:46 a.m. | Source: Devdiscourse
He said such treatments can be used as a bridge to tamp down outbreaks until vaccines are developed. Gilead spokesperson Ashleigh Koss said the company is in contact with global and regional health authorities, noting that obeldesivir is predicted to be active against this strain of Ebola based on preclinical data.
